The targeting selectivity of the trastuzumab-decorated NEs was evaluated in vitro by confocal microscopy on relevant breast cancer models HCC-1954 and SKBR3 (HER2-amplified) and MDA-MB-231 (HER2low). This evidence concerns the gene ERBB2 and breast cancer.